Molecular Templates Inc [NASDAQ: MTEM] stock went on a downward path that fall over -73.48% on Monday, amounting to a one-week price decrease of less than -72.92%.
Over the last 12 months, MTEM stock dropped by -94.20%. The one-year Molecular Templates Inc stock forecast points to a potential upside of 97.83. The average equity rating for MTEM stock is currently 1.00, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $2.57 million, with 6.58 million shares outstanding and 5.44 million shares in the current float. Compared to the average trading volume of 61.47K shares, MTEM stock reached a trading volume of 7011065 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Molecular Templates Inc [MTEM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MTEM shares is $18.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MTEM stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BofA Securities have made an estimate for Molecular Templates Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 21, 2021. While these analysts kept the previous recommendation, UBS raised their target price to Neutral. The new note on the price target was released on February 01, 2021, representing the official price target for Molecular Templates Inc stock. Previously, the target price had yet another raise to $21, while Jefferies analysts kept a Buy rating on MTEM stock.
The Average True Range (ATR) for Molecular Templates Inc is set at 0.17, with the Price to Sales ratio for MTEM stock in the period of the last 12 months amounting to 0.10. The Price to Book ratio for the last quarter was 0.36, with the Price to Cash per share for the same quarter was set at 1.47.
MTEM Stock Performance Analysis:
Molecular Templates Inc [MTEM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -72.92. With this latest performance, MTEM shares dropped by -67.24% in over the last four-week period, additionally sinking by -78.10% over the last 6 months – not to mention a drop of -94.20% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MTEM stock in for the last two-week period is set at 19.84, with the RSI for the last a single of trading hit 13.62, and the three-weeks RSI is set at 24.86 for Molecular Templates Inc [MTEM]. The present Moving Average for the last 50 days of trading for this stock 1.3898, while it was recorded at 1.2442 for the last single week of trading, and 2.0437 for the last 200 days.
Insight into Molecular Templates Inc Fundamentals:
Molecular Templates Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.56 and a Current Ratio set at 1.56.
MTEM Stock EPS
With the latest financial reports released by the company, Molecular Templates Inc posted -0.82/share EPS, while the average EPS was predicted by analysts to be reported at -1.39/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.57. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MTEM. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Molecular Templates Inc go to 3.20%.
Molecular Templates Inc [MTEM] Institutonal Ownership Details
There are presently around $56.12%, or 58.43%% of MTEM stock, in the hands of institutional investors.
